Salivary Gland Cancer
📧 Sign up to get email alerts when something new happens for Salivary Gland Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas [Phase 2]
Phase 2 clinical trial evaluating post-operative T-DM1 in HER2-positive salivary gland carcinomas; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) [Phase 2]
This update reports completion of a Phase 2 trial of darolutamide in patients with androgen receptor–positive salivary gland carcinoma (DISC…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
This entry describes the Head and Neck Registry within the European Reference Network for Rare Adult Solid Cancers, a recruiting registry st…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers [Phase 2]
Phase II study of sacituzumab govitecan for recurrent/metastatic salivary gland cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab combined with chemotherapy for poorly chemo-responsive thyroid and salivary gland cancers …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: APG-115 in Salivary Gland Cancer Trial [Phase 1, Phase 2]
This is an update on a Phase 1/2 trial of APG-115 for salivary gland cancer, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]
Phase 1 study evaluating AVA6000 in solid tumors, assessing safety, pharmacokinetics, and early efficacy; recruitment is ongoing across seve…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers [EARLY_Phase 1]
An early-phase 1 trial at Brigham and Women's Hospital is screening a novel IMD drug in patients with salivary gland cancers and head and ne…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes [NA]
A completed clinical trial evaluating multiple drug therapies for salivary gland cancer guided by genetic testing.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of nivolumab and ipilimumab in patients with salivary gland cancer has completed enrollm…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers [Phase 2]
Update on a Phase 2 trial of lenvatinib plus pembrolizumab in advanced adenoid cystic carcinoma and other salivary gland cancers. The study …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: PDO Based Drug Sensitive Test in R/M SGC
This clinical trial update reports ongoing recruitment for a study evaluating a patient-derived organoid-based drug sensitivity test in recu…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers [Phase 2]
This entry reports a Phase 2 clinical trial of the investigational agent Ivonescimab for advanced, metastatic salivary gland cancers that is…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) [Phase 2]
Phase 2 clinical trial investigating sacituzumab govitecan for metastatic salivary gland and thyroid cancers (SG-SGTC) is currently recruiti…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma [Phase 2]
Phase 2 trial evaluating 9-ING-41 in combination with carboplatin for salivary gland cancer, including adenoid cystic carcinoma; the study i…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Amivantamab in Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 trial of amivantamab for adenoid cystic carcinoma (salivary gland cancer) is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) [Phase 1]
Poseida Therapeutics conducted a Phase 1 trial of P-PSMA-101 CAR-T cells in metastatic castration-resistant prostate cancer and advanced sal…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery [Phase 2]
Phase 2 trial evaluating adjuvant radiation therapy with or without chemotherapy for high-risk malignant salivary gland tumors that have bee…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 with radiation therapy to pembrolizumab for recurrent head and neck squamous cell carcinomas, ai…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating androgen deprivation therapy in patients with advanced salivary gl…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers
This clinical trial update describes gene expression profiling in a validation cohort of locally advanced and recurrent/metastatic salivary …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer [Phase 1]
Phase 1 trial of nab-paclitaxel (albumin-bound paclitaxel) with carboplatin followed by chemoradiation in patients with recurrent head and n…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors [Phase 2]
Phase 2 trial update from Genentech evaluating combinations of Herceptin, Perjeta, Tarceva, Zelboraf, Cotellic, Erivedge, Alecensa, and Tece…